WKN: | 936718 |
ISIN: | US30161Q1040 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Exelixis-Aktie
ein A-Rating hat,
erfahren Sie im Performance-Check
vom 30. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2015 | 1,09 | 5,17 | 374,31% |
2 | 2016 | 5,17 | 14,02 | 171,18% |
3 | 2017 | 14,02 | 25,93 | 84,95% |
4 | 2009 | 3,23 | 5,26 | 62,85% |
5 | 2023 | 14,53 | 21,59 | 48,59% |
6 | 2024 | 21,59 | 32,04 | 48,40% |
7 | 2004 | 5,35 | 7,00 | 30,84% |
8 | 2010 | 5,26 | 6,44 | 22,43% |
9 | 2013 | 3,47 | 4,23 | 21,90% |
10 | 2005 | 7,00 | 7,67 | 9,57% |
11 | 2001 | 16,50 | 17,70 | 7,27% |
12 | 2021 | 16,24 | 16,96 | 4,43% |
13 | 2020 | 16,04 | 16,24 | 1,25% |
14 | 2025 | 32,04 | 32,38 | 1,06% |
15 | 2019 | 16,65 | 16,04 | -3,66% |
16 | 2012 | 3,61 | 3,47 | -3,88% |
17 | 2007 | 6,71 | 5,98 | -10,88% |
18 | 2006 | 7,67 | 6,71 | -12,52% |
19 | 2022 | 16,96 | 14,53 | -14,33% |
20 | 2003 | 6,90 | 5,35 | -22,46% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2014 | 4,23 | 1,09 | -74,23% |
2 | 2002 | 17,70 | 6,90 | -61,02% |
3 | 2008 | 5,98 | 3,23 | -45,99% |
4 | 2011 | 6,44 | 3,61 | -43,94% |
5 | 2018 | 25,93 | 16,65 | -35,79% |
6 | 2003 | 6,90 | 5,35 | -22,46% |
7 | 2022 | 16,96 | 14,53 | -14,33% |
8 | 2006 | 7,67 | 6,71 | -12,52% |
9 | 2007 | 6,71 | 5,98 | -10,88% |
10 | 2012 | 3,61 | 3,47 | -3,88% |
11 | 2019 | 16,65 | 16,04 | -3,66% |
12 | 2025 | 32,04 | 32,38 | 1,06% |
13 | 2020 | 16,04 | 16,24 | 1,25% |
14 | 2021 | 16,24 | 16,96 | 4,43% |
15 | 2001 | 16,50 | 17,70 | 7,27% |
16 | 2005 | 7,00 | 7,67 | 9,57% |
17 | 2013 | 3,47 | 4,23 | 21,90% |
18 | 2010 | 5,26 | 6,44 | 22,43% |
19 | 2004 | 5,35 | 7,00 | 30,84% |
20 | 2024 | 21,59 | 32,04 | 48,40% |